Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
TRF2 as novel marker of tumor response to taxane-based therapy: from mechanistic insight to clinical implication.
Iachettini S; Terrenato I; Porru M; Di Vito S; Rizzo A; D'Angelo C; Petti E; Dinami R; Maresca C; Di Benedetto A; Palange A; Mulè A; Santoro A; Palazzo A; Fuso P; Stoppacciaro A; Vici P; Filomeno L; Di Lisa FS; Arcuri T; Krasniqi E; Fabi A; Biroccio A; Zizza P.
J Exp Clin Cancer Res
(Unknown)
Published: 2024
Inhibition of MER proto-oncogene tyrosine kinase by an antisense oligonucleotide enhances treatment efficacy of immunor…
Hu Y; Revenko A; Barsoumian H; Bertolet G; Fowlkes NW; Maazi H; Green MM; He K; Sezen D; Voss TA; Leyton CSK; Masrorpour F; Rafiq Z; Puebla-Osorio N; Leuschner C; MacLeod R; Cortez MA; Welsh JW.
J Exp Clin Cancer Res
(Unknown)
Published: 2024
PARP1-targeted fluorescence molecular endoscopy as novel tool for early detection of esophageal dysplasia and adenocarc…
Marcazzan S; Braz Carvalho MJ; Nguyen NT; Strangmann J; Slotta-Huspenina J; Tenditnaya A; Tschurtschenthaler M; Rieder J; Proaño-Vasco A; Ntziachristos V; Steiger K; Gorpas D; Quante M; Kossatz S.
J Exp Clin Cancer Res
(Unknown)
Published: 2024
Tumorigenesis of basal muscle invasive bladder cancer was mediated by PTEN protein degradation resulting from SNHG1 upr…
Li T; Huang M; Sun N; Hua X; Chen R; Xie Q; Huang S; Du M; Zhao Y; Lin Q; Xu J; Han X; Zhao Y; Tian Z; Zhang Y; Chen W; Shen X; Huang C.
J Exp Clin Cancer Res
(Unknown)
Published: 2024
FBW7/GSK3β mediated degradation of IGF2BP2 inhibits IGF2BP2-SLC7A5 positive feedback loop and radioresistance in lung c…
Zhou Z; Zhang B; Deng Y; Deng S; Li J; Wei W; Wang Y; Wang J; Feng Z; Che M; Yang X; Meng J; Li Y; Hu Y; Sun Y; Wen L; Huang F; Sheng Y; Wan C; Yang K.
J Exp Clin Cancer Res
(Unknown)
Published: 2024
A complex of cadherin 17 with desmocollin 1 and p120-catenin regulates colorectal cancer migration and invasion accordi…
Bartolomé RA; Pintado-Berninches L; Martín-Regalado Á; Robles J; Calvo-López T; Ortega-Zapero M; Llorente-Sáez C; Boukich I; Fernandez-Aceñero MJ; Casal JI.
J Exp Clin Cancer Res
(Unknown)
Published: 2024
Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy.
Meraz-Torres F; Niessner H; Plöger S; Riel S; Schörg B; Casadei N; Kneilling M; Schaller M; Flatz L; Macek B; Eigentler T; Rieß O; Garbe C; Amaral T; Sinnberg T.
J Exp Clin Cancer Res
(Unknown)
Published: 2024